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A B S T R A C T
A relationship between the infecting dose and the risk of disease severity has not been demonstrated for
SARS-CoV-2 infection. Here, we report three clusters of individuals that were potentially exposed to
distinct inoculum in Madrid. Overall each group developed divergent clinical forms of COVID-19. Our data
support that a greater viral inoculum at the time of SARS-CoV-2 exposure might determine a higher risk
of severe COVID-19.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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disease severity has been demonstrated for several viral infections,
including influenza and SARS (Hijano et al., 2019; Chu et al., 2004).
For COVID-19, high viral loads either in saliva, respiratory
secretions, or blood have been associated with more severe illness
(Xu et al., 2020; To et al., 2020). However, it remains unclear
whether exposure to a greater viral inoculum could determine a
higher risk for developing severe COVID-19. Although intuitive, it
has been challenging to obtain such dose-response data.
Herein we report three clusters of SARS-CoV-2 infection in
Madrid, in which infected persons experienced divergent clinical
outcomes, namely severe, mild, or asymptomatic. We hypothesize
that distinct sizes of viral inoculum at the time of exposure could
explain their different illness course.
The first cluster was represented by 25 women (age range, 34 to
86 years-old) that lived in a community located on the outskirts of
Madrid. The house was large (2000 m2), with three floors, spacious
typical ballrooms and halls, high ceilings, large rooms, and a big* Corresponding author at: UNIR Health Sciences School & Medical Center, Calle
Almansa 101, Madrid 28040, Spain.
E-mail address: vicente.soriano@unir.net (V. Soriano).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).garden (1500 m2). Lockdown with strict stay home confinement
was declared in Madrid on March 14. The day before, the index
case, a 47-year-old woman was shopping and visiting relatives. On
March 16, she developed fever, cough, anosmia, and dysgeusia.
Despite isolation at her room, two household members developed
mild symptoms 2-3 days later and another 15 during the following
two weeks. Antibody tests performed on April 28 to all 25 residents
identified three additional infected asymptomatic persons, where-
as four remained seronegative (Fig. 1). In this cluster, low viral
exposures and social distancing would account for more benign
clinical forms of COVID-19, along with asymptomatic and
uninfected cases.
A second cluster of COVID-19 was identified in a group of 12
women (age range, 53 to 85 years-old) that lived together in an
apartment flat (650 m2) in downtown Madrid. Several of them
admitted going outside their home multiple times despite
lockdown implementation. Furthermore, many acknowledged
poor compliance with social distancing measures. Therefore, more
than one index case could be expected in this site. From March 21th
to 23rd, six of them developed mild to severe COVID-19 symptoms
and asked for medical assessment at home or nearby clinics. Three
developed bilateral pneumonia, one being hospitalized and
requiring intensive care support. From March 25 to April 3,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Fig. 1. The timeframe of SARS-CoV-2 infections and COVID-19 disease severity in persons belonging to groups with different viral exposure.
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hospitalized with bilateral pneumonia. Antibody tests on April 28
confirmed infection in all 12 residents, including two that had
remained asymptomatic. In this cluster, indoor continuous viral
exposure could account for a broader presentation of clinical forms
of COVID-19, given that all residents were infected.
The third cluster consisted of a group of ten adults (seven male;
age range, 56 to 76 years-old) that met in a small conference room
(60 m2) for three hours on March 4, ten days before the nationwide
lockdown was implemented. The event was held at a health
institution in downtown Madrid. Three attendees had just arrived
from Rome (two) and Milan (one), where they had been for a few
days. All attendees were asymptomatic on the meeting day and did
not take any preventive measures, including sitting next to each
other and not wearing face masks. Two days later, two developed
COVID-19 symptoms and the rest also did within the next week.
COVID-19 was severe in at least four individuals, one being
hospitalized at the intensive care unit for nearly one month.
Fortunately, he recovered. This cluster reminds one of many
features of a large outbreak reported among members of a choir inFig. 2. Major determinants of SARS-CoV-2 susceptiWashington, USA (Hamner et al., 2020). In this cluster, an extensive
indoor viral exposure seemed to account for all attendees' infection
and the development of severe clinical forms in half of them.
It is worth noting that of the six major determinants of SARS-
CoV-2 susceptibility to infection and risk for disease severity
(Fig. 2), the first two clusters only included women, whereas seven
out of ten in the last cluster were male. The mean ages (63.4, 66.3,
62.7 years old, respectively) and the rate of chronic co-morbidities
(roughly two-thirds of each group, with hypertension the most
common) did not differ significantly in comparing the three
clusters. Information on potential cross-immunity with other
endemic coronaviruses or genetic variants that could influence the
SARS-CoV-2 disease course, was not available, but all individuals
were living in Madrid and were Caucasian. Therefore, we
hypothesize that a different inoculum at the time of SARS-CoV-2
exposure could explain the different course of infection in these
three clusters.
Intriguingly, most recent SARS-CoV-2 infections seem to be less
virulent than those that occurred earlier in the COVID-19 outbreak
(Pan et al., 2020; Little et al., 2020). Several factors mightbility to infection and risk for disease severity.
Fig. 3. Herd immunity needed to halt the COVID-19 pandemic as a function of the
average community transmission rate (R0).
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presentations at the beginning of the pandemic. Alternatively,
the new coronavirus could steadily become less pathogenic, as
result of co-adaptation to human hosts (Martinez, 2020). However,
our findings suggest that it most likely reflects the overall lower
size of the inoculum in recent infections due to extensive social
distancing interventions compared to contagions that occurred
earlier in the pandemic.
The recognition that exposure to low viral loads is associated
with mild or asymptomatic infections would favor a sensible
gradual re-opening of activities. For instance, restricting indoor
gatherings where superspreading events are more likely to occur
will have a significant impact on transmission, whereas other
restrictions —on outdoor activity, for example— might be eased.
Promoting activities in open spaces, coupled with rapid isolation of
symptomatic persons (self-confinement) and quarantine of con-
tacts would act synergistically to halt COVID-19 spread and
severity (Cowling et al., 2020).
Since overall 80% of the contagions seem to have derived from
only 10% of infected individuals (Jarvis et al., 2020), shifting the
SARS-CoV-2 community transmission rate (R0) to less than 2
would require that less than half of the population would need to
be infected to produce herd immunity (Fig. 3). In this scenario,
COVID-19 spreading would be expected to be controlled, even inthe absence of antivirals or vaccines. Our data support the proposal
that keeping social distancing would be effective in reducing
contagions as well as driving COVID-19 to less severe forms. This
information is crucial when re-opening strategies are urgently
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